Apixaban API has been approved by China NMPA
One step further with Apixaban. We are happy to announce that Apixaban API has been approved by China NMPA.
🎉🎉 This is a significant milestone for our company. Really great job from our regulatory, intellectual property, manufacturing and business development departments based in Malta, Spain and China!
Do you want to get more information? Contact us; email@example.com; or if you prefer, meet us in person next week! at stand 14F70 in the #cphi2021